Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03575572 · ClinicalTrials.gov registry record · Phase 2
Colchicine in Postoperative Fontan Patients
A Phase 2 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT03575572 is a Phase 2 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 11 participants.
The verdict
NCT03575572, a Phase 2 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
The investigators found that there is inflammation in the chest drainage in patients after the Fontan operation. The investigators want to test the theory that Colchicine, an anti- inflammatory medication, can decrease the inflammation in the chest tube drainage after the Fontan operation, and can decrease the amount of time that patients having this surgery will have drainage.
Interventions
- DRUG Colchicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-08-29 |
| Est. Completion | 2021-01-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03575572
The ClinicalTrials.gov registry entry for NCT03575572 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Colchicine is the first listed.
NCT03575572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03575572 about?
NCT03575572 is a clinical study titled "Colchicine in Postoperative Fontan Patients". The investigators found that there is inflammation in the chest drainage in patients after the Fontan operation. The investigators want to test the theory that Colchicine, an anti- inflammatory medication, can decrease the inflammation in the chest tube drainage after the Fontan operation, and can d...
What is the current status of trial NCT03575572?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2018-08-29. Estimated completion is 2021-01-13.
What interventions are being tested in trial NCT03575572?
The interventions under investigation include: Colchicine (DRUG).
Who is sponsoring clinical trial NCT03575572?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.